An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity
Author:
Affiliation:
1. Kalobios Pharmaceuticals, Inc., 260 East Grand Avenue, South San Francisco, California 94080
2. Department of Anesthesia and Perioperative Care, University of California, San Francisco, 35 Lucerne Street #3, San Francisco, California 94103
Abstract
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Link
https://journals.asm.org/doi/pdf/10.1128/IAI.00815-08
Reference34 articles.
1. Chapman, A. P., P. Antoniw, M. Spitali, S. West, S. Stephens, and D. J. King. 1999. Therapeutic antibody fragments with prolonged in vivo half-lives. Nat. Biotechnol.17:780-783.
2. Chapman, A. P. 2002. PEGylated antibodies and antibody fragments for improved therapy: a review. Adv. Drug Deliv. Rev.54:531-545.
3. Pseudomonas aeruginosa Cystic Fibrosis Isolates Induce Rapid, Type III Secretion-Dependent, but ExoU-Independent, Oncosis of Macrophages and Polymorphonuclear Neutrophils
4. Dacheux, D., J. Goure, J. Chabert, Y. Usson, and I. Attree. 2001. Pore-forming activity of type III system-secreted proteins leads to oncosis of Pseudomonas aeruginosa-infected macrophages. Mol. Microbiol.40:76-85.
5. Characterization of a Humanized Monoclonal Antibody Recognizing Clumping Factor A Expressed by Staphylococcus aureus
Cited by 104 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Monoclonal antibodies derived from B cells in subjects with cystic fibrosis reducePseudomonas aeruginosaburden in mice;2024-04-12
2. Management of Non-Ventilated hospital acquired pneumonia;Clinical Infection in Practice;2024-01
3. Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa;Cell;2023-11
4. Anti-virulence compounds against Staphylococcus aureus associated with bovine mastitis: A new therapeutic option?;Microbiological Research;2023-06
5. Immunotargeting of Gram-Positive Pathogens via a Cell Wall Binding Tick Antifreeze Protein;Journal of Medicinal Chemistry;2022-12-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3